Renoprotective potency of amifostine in rat renal ischaemiareperfusion

Nephrology Dialysis Transplantation

Volumn 25, Issue 12, 2010, Pages 3845-3851

  Chok, Mohammed Koussai ^a   Conti, Marc ^a   Almolki, Abdelhamid ^b   Ferlicot, Sophie ^a   Loric, Sylvain ^c   Dürrbach, Antoine ^a   Benot, Gérard ^a   Droupy, Stéphane ^a   Eschwège, Pascal ^a,d  

^a BICÊTRE HOSPITAL   (France)

^b INSERM   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d CHU NANCY BRABOIS   (France)

Author keywords

amifostine; cyclooxygenase; ischaemiareperfusion; kidney; reactive oxygen species

Indexed keywords

AMIFOSTINE; CASPASE 3; CREATININE; CYCLOOXYGENASE 2; MALONALDEHYDE; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN SYNTHASE;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG POTENCY; KIDNEY INJURY; KIDNEY ISCHEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; REPERFUSION INJURY;

EID: 78649493637     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq314     Document Type: Article

References (35)

1. Bird JE, Milhoan K, Wilson CB et al. Ischemic acute renal failure and antioxidant therapy in the rat. The relation between glomerular and tubular dysfunction. J Clin Invest 1988; 81: 1630
2. Weinberg JM. The cell biology of ischemic renal injury. Kidney Int 1991; 39: 476 Review
3. Myers S, Wang L, Liu F et al. Oxygen-radical regulation of renal blood flow following suprarenal aortic clamping. J Vasc Surg 2006; 43: 577
4. Stallwood MI, Grayson AD, Mills K et al. Acute renal failure in coronary artery bypass surgery: independent effect of cardiopulmonary bypass. Ann Thorac Surg 2004; 77: 968
5. Paller MS, Holdal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156
6. Bonventre JV, Weinberg JM. Recent adVances in the pathophysi-ology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199
7. Wang J-L, Cheng H-F, Zhang M-Z et al. Selective increase of cy-clooxygenase-2 expression in a model of renal ablation. Am J Physiol Ren Physiol 1998; 275: F613
8. Allen DA, Harwood SM, Varagunam M et al. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J 2003; 17: 908
9. Weichert-Jacobsen KJ, Bannowski A, Küppers F et al. Direct amifos-tine effect on renal tubule cells in rats. Cancer Res 1999; 59: 3451
10. Koukourakis MI. Amifostine in clinical oncology: current use and future applications. Anticancer Drugs 2002; 13: 181
11. Spencer CM, Goa KL. Amifostine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radio-protector and cytotoxic chemoprotector. Drugs 1995; 50: 1001
12. Capizzi RL. The preclinical basis for broad-spectrum selective cyto-protection of normal tissues from cytotoxic therapies by amifostine (Ethyol). Eur J Cancer 1996; 32A: S5
13. Conger JD, Schultz MF, Miller F et al. Response to hemorrhagic arterial pressure reduction in different ischemic renal failure models. Kidney Int 1994; 46/318
14. Conti M, Morand PC, Levillain P et al. Improved fluorimetric determination of malonaldehyde. Clin Chem 1991; 37: 1273
15. Johansson LH, Borg LA. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 1988; 174: 331
16. Gill N, Nally JV, Fatica RA. Failure secondary to acute tubular necrosis: epidemiology, diagnosis, and management. Chest 2005; 128: 2847
17. Boom H, Paul LC, de Fijter JW. Delayed graft function in renal transplantation. Transplant Rev 2004; 18: 139
18. Schrier RW, Wang W, Poole B et al. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004; 114: 5
19. McCord JM, Edeas MA. SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother 2005; 59: 139
20. Matsuyama M, Yoshimura R. Study of cyclooxygenase-2 in renal ischemia-reperfusion injury. Transplant Proc 2005; 37: 370
21. Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB et al. Ischemia/re-perfusion injury. J Surg Res 2002; 105: 248
22. Padanilam BJ. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Ren Physiol 2003; 284: F608
23. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1
24. Lieberthal W, Koh JS, Levine JS. Necrosis and apoptosis in acute renal failure. Semin Nephrol 1998; 18: 505
25. Marzatico F, Porta C, Moroni M et al. In vitro antioxidant properties of amifostine (WR-2721, Ethyol). Cancer Chemother Pharmacol 2000; 45: 172
26. Ramakrishnan N, Catravas GN. N-(2-mercaptoethyl)-1,3-propanedia-mine (WR-1065) protects thymocytes from programmed cell death. J Immunol 1992; 148: 1817
27. Porta C, Maiolo A, Tua A et al. Amifostine, a reactive oxygen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Haemato-logica 2000; 85: 820
28. Valdivielso JM, Crespo C, Alonso JR et al. Renal ischemia in the rat stimulates glomerular nitric oxide synthesis. Am J Physiol Regul In-tegr Comp Physiol 2001; 280: R771
29. Damron TA, Mathur S, Horton JA et al. Temporal changes in PTHrP, Bcl-2, Bax, caspase, TGF-beta, and FGF-2 expression following growth plate irradiation with or without radioprotectant. J Histochem Cytochem 2004; 52: 157
30. Sinisalo J, Paronen J, Mattila KJ et al. Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis 1999; 149: 403
31. Feitoza CQ, Camara NOS, Pinheiro HS et al. Cyclooxygenase 1 and/ or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion. Int Immunopharmacol 2005; 5: 79
32. Ogata K, Jin MB, Taniguchi M et al. Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospho-lipase A2 with LY329711. Transplantation 2001; 71: 1040
33. Doi K, Suzuki Y, Nakao A et al. Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 2004; 65: 1714
34. Singh D, Chander V, Chopra K. Protective effect of catechin on ischemia-reperfusion-induced renal injury in rats. Pharmacol Rep 2005; 57: 70
35. Bolaman Z, Cicek C, Kadikoylu G et al. The protective effects of amifostine on adriamycin-induced acute cardiotoxicity in rats. Tohoku J Exp Med 2005; 207: 249